Disopyramide in hypertrophic cardiomyopathy II. Noninvasive assessment after oral administration

This publication has 14 references indexed in Scilit:

• Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration
  The American Journal of Cardiology, 1988
• Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
  Progress in Cardiovascular Diseases, 1985
• Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient.
  Circulation, 1984
• Muscular Subaortic Stenosis
  New England Journal of Medicine, 1982
• The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
  Circulation, 1982
• Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
  The American Journal of Cardiology, 1981
• Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.
  Circulation, 1981
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.
  Circulation, 1979
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
  Circulation, 1979
• Muscular Subaortic Stenosis
  Circulation, 1968